Cardiac Arrhythmias 2001 : Proceedings of the 7th International Workshop on Cardiac Arrhythmias (Venice, 7-10 October 2001)

Front Matter....Pages I-XX Front Matter....Pages 1-1 Progress in Arrhythmia and Sudden Cardiac Death Research Support....Pages 3-10 Front Matter....Pages 11-11 Syncope or Drop Attack?....Pages 13-18 Syncope or Seizures: What Have We Learned from Electrocardiographic Monitoring?....Pages 19-21 Postprandial Hypotension: Pathophysiology and Management....Pages 22-28 Psychogenic Syncope: How Frequent Is It?....Pages 29-37 Syncope with Exercise: Mechanisms and Management....Pages 38-42 The Postural Tachycardia Syndrome: Etiology, Diagnosis and Treatment....Pages 43-49 Syncope in Hypertrophic Cardiomyopathy: What are the Potential Mechanisms and Therapeutic Implications?....Pages 50-56 Intraventricular Conduction Disturbances and Negative Electrophysiologic Study in Patients with Syncope: What Should One Do?....Pages 57-60 Unexplained Syncope with Inducible Sustained Ventricular Arrhythmias: to Implant or Not to Implant an ICD?....Pages 61-66 Syncope and ICD: What Are the Implications and Recommendations for Driving?....Pages 67-74 Therapy of Vasovagal Syncope: Is There a Role for Drugs Today?....Pages 75-82 Pacing for Vasovagal Syncope: Real Efficacy or Placebo Effect?....Pages 83-89 Prevention of Vasovagal Syncope by Pacing: How to Select Patients and Which Pacing Mode to Choose....Pages 90-96 Front Matter....Pages 97-97 How Many Patients Really Need Ventricular Resynchronization Therapy?....Pages 99-102 What Are the Clinical Benefits of Biventricular Pacing in Heart Failure Patients?....Pages 103-108 Neurohormonal and Anatomical Remodeling After Ventricular Resynchronization Therapy: Does It Really Happen?....Pages 109-113 Is Echocardiography Useful for Selecting Patients with Heart Failure as Candidates for Ventricular Resynchronization Therapy?....Pages 114-120 Is Acute Hemodynamic-Angiographic Evaluation Necessary Before Implantation of a Left Ventricular-Based Pacemaker?....Pages 121-124 Cardiac Resynchronization Therapy: Is There Any Correlation Between Pacing Site and Hemodynamic Improvement?....Pages 125-133 Front Matter....Pages 97-97 Does Atrial Resynchronization Confer Further Benefit on Patients Undergoing Ventricular Resynchronization Therapy?....Pages 134-139 Ventricular Resynchronization Therapy in Heart Failure Patients with Chronic Atrial Fibrillation: Is It Worthwhile ?....Pages 140-146 Ventricular Resynchronization Therapy: How to Follow Implanted Patients....Pages 147-150 How Great Is the Arrhythmic Risk for Heart Failure Patients and Does Resynchronization Therapy Modify It?....Pages 151-156 Does Cardiac Resynchronization Therapy Diminish the Need for Tachyarrhythmia Therapy?....Pages 157-162 Patients Undergoing ICD Implantation: How Many Need Biventricular Pacing?....Pages 163-169 Multisite Pacing in ICD Patients: Which Benefits?....Pages 170-180 Ventricular Resynchronization: What May We Expect from Technological Advances?....Pages 181-184 Front Matter....Pages 185-185 Catecholaminergic Polymorphic Ventricular Tachycardia: Another Inherited Arrhythmia?....Pages 187-190 The Link Between SIDS and Long QT Syndrome: from Theory to Evidence....Pages 191-197 Brugada Sign: What Is the Prevalence in an Apparently Healthy Population?....Pages 198-205 Asymptomatic Patients with Brugada Syndrome: Does the Risk of Sudden Death Justify ICD Implantation?....Pages 206-211 Will the Spectrum of Ion Channel Diseases Increase Further in the Near Future?....Pages 212-218 Left Ventricular Hypertrophy: A Neglected Risk Factor for Sudden Cardiac Death?....Pages 219-227 Post-Extrasystolic Heart Rate Turbulence as a Risk Predictor: What are the Perspectives and Limitations?....Pages 228-236 T-Wave Alternans, a Powerful Index for Malignant Ventricular Arrhythmias-Fact or Fiction?....Pages 237-247 Prevention of Sudden Death in Different Realities: Can We Reach a Consensus?....Pages 248-253 Drug Prevention of Sudden Death after Myocardial Infarction: Role of Angiotensin Converting Enzyme Inhibitors....Pages 254-257 Post-Infarction: When and How to Use Amiodarone....Pages 258-260 Amiodarone and ß-Blockers: Why This Combination?....Pages 261-265 Front Matter....Pages 185-185 Impact of MADIT and MUSTT on Clinical Practice....Pages 266-270 How Many ICD Recipients Really Need Dual-Chamber Pacing?....Pages 271-280 Front Matter....Pages 281-281 Acute Termination of Atrial Flutter: Are New Class Antiarrhythmic Drugs the Best Choice?....Pages 283-290 Typical Atrial Flutter: Antiarrhythmic Drugs or Ablation as First-Line Therapy?....Pages 291-300 What Is the Most Accurate and Simple Method to Assess Block Through the Cavotricuspid Isthmus?....Pages 301-305 Class IC/Amiodarone Atrial Flutter: What Are the Long-Term Results of Radiofrequency Ablation?....Pages 306-312 Diagnosis and Treatment of Atrial Flutter Circuits....Pages 313-319 Is Inappropriate Sinus Tachycardia Really Inappropriate?....Pages 320-323 “Pill in The Pocket” or Chronic Drug Prophylaxis for Patients with Paroxysmal Supraventricular Tachycardias without Indication for Catheter Ablation?....Pages 324-328 Ablation of Fast and/or Slow Pathway for AV Nodal Reentrant Tachycardia: What Is the Risk of Late Block?....Pages 329-335 What Are the Accuracy and Limitations of Published Algorithms Using Surface ECG to Localize Overt AV Accessory Pathways?....Pages 336-342 Front Matter....Pages 343-343 Electrical and Mechanical Remodeling of the Atria: What Are the Underlying Mechanisms, the Time Course and the Clinical Relevance?....Pages 345-352 “Lone” Atrial Fibrillation: How “Lone” Is It?....Pages 353-355 Focal Atrial Fibrillation: Which Clinical/Electrocardiographic Pattern?....Pages 356-360 Atrial Fibrillation Complicated by Heart Failure: First the Chicken or First the Egg?....Pages 361-368 Asymptomatic Atrial Fibrillation: How Frequent Is It? What Are the Practical/Therapeutic Implications?....Pages 369-372 Does Early Echocardiography-Guided Cardioversion of Atrial Fibrillation Prevent Electrical/Mechanical Remodeling of the Atria?....Pages 373-377 The “Pill in the Pocket” Approach for Paroxysmal Atrial Fibrillation: How Effective and Safe Is It?....Pages 378-382 Class IC Drug Plus Ibutilide for Acute Cardioversion of Atrial Fibrillation: What Is the Rationale and What Are the Results?....Pages 383-388 What Is the Role of Internal Low-Energy Cardioversion Today, in the Era of External Biphasic Shock?....Pages 389-393 Front Matter....Pages 343-343 Early Recurrences of Atrial Fibrillation: How to Predict and Avoid Them?....Pages 394-400 Reversal of Atrial Stunning After Cardioversion: What Are the Time Course and Clinical-Therapeutic Implications?....Pages 401-406 Signal-Averaged P-Wave: How Useful Is It in Identifying Patients at High Risk of Recurrences after Cardioversion?....Pages 407-412 Prevention of Atrial Fibrillation: Is Amiodarone a First Choice?....Pages 413-417 Antiarrhythmic Drug Prophylaxis to Avoid Permanent Atrial Fibrillation: Is it Worthwhile?....Pages 418-421 Antiplatelet Agents for Prevention of Thromboembolism in Atrial Fibrillation: When, Why, and Which One?....Pages 422-435 Self-management of Oral Anticoagulants by Patients with Atrial Fibrillation: How Effective and Safe Is It?....Pages 436-440 Front Matter....Pages 441-441 Focal Atrial Fibrillation: The Bordeaux Experience....Pages 443-446 Milan Experience of Catheter Ablation for Atrial Fibrillation....Pages 447-452 Catheter Ablation of Focal Atrial Fibrillation: Taiwan Experience....Pages 453-456 Ablation of Atrial Fibrillation: The Cleveland Clinic Experience....Pages 457-464 Worldwide Experience in Surgical Treatment of Atrial Fibrillation....Pages 465-468 Surgical Treatment of Atrial Fibrillation: The Japanese Experience....Pages 469-474 Intraoperative Radiomaze for Atrial Fibrillation Patients Undergoing Heart Surgery: Which Acute and Long Term Results?....Pages 475-478 Implantable Atrial Defibrillator: Where Are We and Where Are We Going?....Pages 479-484 Atrial Pacing to Prevent Atrial Fibrillation: Is There Any Evidence of Its Real Efficacy?....Pages 485-491 Is Overdrive Pacing Useful for the Prevention of Paroxysmal Atrial Fibrillation?....Pages 492-497 Which Patients with Atrial Fibrillation Benefit Most from Overdrive Pacing?....Pages 498-503 Brady-Tachy Syndrome: What Is the Best Pacing Technique To Reduce the Burden of Atrial Fibrillation?....Pages 504-509 Patients with Paroxysmal Atrial Fibrillation Undergoing “Ablate and Pace” Therapy: Is Prevention of Arrhythmic Recurrences Possible by Combined Overdrive and Biatrial Pacing?....Pages 510-518 Front Matter....Pages 441-441 ICD Patients: What Is the Efficacy of Early Activation of Atrial ATP Therapies in Atrial Fibrillation Termination?....Pages 519-522 Might a Better Understanding of Atrial Electrophysiology Help Atrial Fibrillation Treatment?....Pages 523-529 Circadian Patterns of Atrial Fibrillation Onset Mechanism: Can Pacing Be Influential?....Pages 530-535 Can Ventricular Rate Stabilisation Reduce Symptoms of Atrial Fibrillation?....Pages 536-541 Novel Pacing Algorithms Applied in Hybrid Therapies of Atrial Fibrillation: The Ultimate Solution?....Pages 542-546 Front Matter....Pages 547-547 Advanced Patient Management Using Knowledge-Based Systems....Pages 549-555 Single-Lead Dual Chamber Pacing: How Reliable and Effective Is It?....Pages 556-565 Hemodynamic Sensors: Are They All the Same?....Pages 566-575 Hemodynamic Sensors: What Clinical Value Do They Have in Heart Failure?....Pages 576-585 How Reliable and Effective Are Hemodynamic Sensors in Correcting Chronotropic Incompetence?....Pages 586-594 Hemodynamic Sensors: What Clinical Value Do They Have in Chronotropic Incompetence?....Pages 595-601 Hemodynamic Sensors: Clinical Value in Vasovagal Syncope....Pages 602-607 Sophisticated Pacemaker Diagnostics: Are They Really Useful in Clinical Practice?....Pages 608-612 Pacemaker Automaticity: Real Progress or Increased Complexity and Costs?....Pages 613-617 Pacemaker/ICD Lead Infection: What Are the Main Intracardiac Echocardiographic Features?....Pages 618-622 Percutaneous Extraction of Infected Pacemaker/ICD Leads: What Are the Current Technological Advances and Results?....Pages 623-630 Interference to Pacemaker/ICD Function by Commonly Encountered Electronic Devices: When and How Much to Worry About?....Pages 631-645 Biventricular Pacing: How to Predict the Clinical Response in the Single Patient?....Pages 646-653 Back Matter....Pages 655-657